MatchMiner: an open-source platform for cancer precision medicine

Widespread, comprehensive sequencing of patient tumors has facilitated the usage of precision medicine (PM) drugs to target specific genomic alterations. Therapeutic clinical trials are necessary to test new PM drugs to advance precision medicine, however, the abundance of patient sequencing data co...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Harry, Mazor, Tali, Siegel, Ethan, Trukhanov, Pavel, Ovalle, Andrea, Vecchio Fitz, Catherine Del, Zwiesler, Zachary, Kumari, Priti, Van Der Veen, Bernd, Marriott, Eric, Hansel, Jason, Yu, Joyce, Albayrak, Adem, Barry, Susan, Keller, Rachel B., MacConaill, Laura E., Lindeman, Neal, Johnson, Bruce E., Rollins, Barrett J., Do, Khanh T., Beardslee, Brian, Shapiro, Geoffrey, Hector-Barry, Suzanne, Methot, John, Sholl, Lynette, Lindsay, James, Hassett, Michael J., Cerami, Ethan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537311/
https://www.ncbi.nlm.nih.gov/pubmed/36202909
http://dx.doi.org/10.1038/s41698-022-00312-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537311/
https://www.ncbi.nlm.nih.gov/pubmed/36202909
http://dx.doi.org/10.1038/s41698-022-00312-5

Ejemplares similares